Handing the surgeon’s scalpel to a robot
After decades of merely assisting doctors, are sophisticated machines ready to take charge?
CRISPR infusion eliminates swelling in those with rare genetic disease
Company reports first benefits to patients from injecting the molecular gene-editing tool into the blood
Bluebird wins FDA approval of gene therapy for rare brain disorder
The therapy, cleared to treat cerebral adrenoleukodystrophy, is the product of more than a decade of work by Bluebird. It will cost $3 million.
Modeling embryonic circulation, researchers produce elusive precursor blood stem cells
How the immune system shapes neurodegenerative diseases
Novo Nordisk Foundation issues $200M grant to apply quantum computing to life sciences, drug discovery
China bets big on brain research with massive cash infusion and openness to monkey studies
Ambitious $746 million program aims to complement big neuroscience projects in Europe and the United States
The controversial embryo tests that promise a better baby
Some companies offer tests that rank embryos based on their risk of developing complex diseases such as schizophrenia or heart disease. Are they accurate — or ethical?
Genetically modified purple tomatoes receive US approval
Four years in the making, AbbVie and Calibr provide first look into ‘switchable’ CAR-T program
Can quantum computing really disrupt the pharma industry?
Will quantum computing be a massive breakthrough for the pharma industry? Or is it all just hype?
Are $3M gene therapies the new normal? Experts say bluebird will be a test case for a market ready for prime time
Servier cuts ties with Allogene, ending complex CAR-T partnership
The French drugmaker terminated a nearly decade-old deal that helped Allogene emerge as the sector’s largest “off-the-shelf” cell therapy developer.
NIH launches the next stage of its ‘human genome project’ for the brain
AlphaFold Developers Win $3-Million Breakthrough Prize in Life Sciences
DeepMind’s system for predicting the 3D structure of proteins is among five recipients of science’s most lucrative awards
Multimodal biomedical AI
Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial
Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases
There’s New Proof Crispr Can Edit Genes Inside Human Bodies
The technique had largely been limited to editing patients’ cells in the lab. New research shows promise for treating diseases more directly.
FDA advisers back microbiota-based treatment for gut infection